摘要:
Objective:To investigate the therapeutic effects of the Medical Instrument on Hepatic Diseases of DSG Ⅲ type in the treatment of patients with chronic liver disease.Methods:Sixty patients of chronic liver disease were enrolled in the study,and randomly divided into treatment group and control group.The control group(n=29)were treated with conventional drug therapy.And the treatment group(n=31)were treated with conventional ther-apy plus the Medical Instrument on Hepatic Diseases of DSG Type for 30 min each time,twice daily.Serum levels of ALT,AST,DBIL,IBIL,γ-GT,ALP,ALB and GLB were evaluated before the treatment and at 2 wk after the treat-ment.Meanwhile,clinical symptoms(fatigue,anorexia,abdominal distension,liver discomfort)were observed.Re-sults:After treatment,serum levels of ALT,AST,DBIL,IBIL,ALP and γ-GT decreased markedly(all P0.05).Decreased levels of ALT,AST,DBIL and IBIL were also noted in control group,but γ-GT,ALP,ALB and GLB were not statistically significant.On the condition of the com-parable baseline,levels of ALT after the treatment were statistical significance between treatment group and control group[(42 ± 28)IU/L vs(86 ± 71)IU/L(P0.05).Conclusion:Treatment with Medical Instrument on Hepatic Diseases of DSG Ⅲ type can improve the curative effect and relieve clinical symptoms in chronic liver disease.%目的:评估DSG-Ⅲ型生物信息红外肝病治疗仪(BIL T 肝病治疗仪)治疗慢性肝病的临床疗效.方法:选择慢性肝病60例,随机分为治疗组和对照组.对照组(n=29)以药物常规治疗,治疗组(n=31)在常规治疗的基础上加用BIL T 肝病治疗仪照射肝区(治疗时间为30 min,2次/d),在治疗前及治疗2周后,观察两组临床症状(乏力、纳差、腹胀、肝区不适)及肝功能指标(包括ALT、AST、DBIL、IBIL、γ-GT、ALP、ALB、GLB)的变化.结果:与治疗前比较,治疗组肝功能ALT、AST、DBIL、IBIL、ALP、γ-GT均显著降低(P0.05).结论:BIL T 肝病治疗仪配合药物较单纯药物治疗慢性肝病可提高疗效,缓解患者部分临床症状.